Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer's Message To Wall Street: We're Doing Things Differently Now

This article was originally published in The Pink Sheet Daily

Executive Summary

Exubera's failure was a defining moment for CEO Jeff Kindler, who says the episode motivated him to transform the way Pfizer makes decisions.

You may also be interested in...



MannKind CEO Is Optimistic About Near-Term Approval of Afrezza

One industry watcher at the J.P. Morgan conference says the company is like a "teenager," there's always an explanation.

MannKind CEO Is Optimistic About Near-Term Approval of Afrezza

One industry watcher at the J.P. Morgan conference says the company is like a "teenager," there's always an explanation.

MannKind CEO Is Optimistic About Near-Term Approval Of Afrezza

MannKind CEO Alfred Mann played down a regulatory delay of the company's rapid-acting inhaled recombinant insulin product Afrezza and, in response to questions, refused to acknowledge that finding a partner could be tough, during a presentation and subsequent breakout session at the J.P. Morgan Healthcare Conference on Jan. 12

Related Content

Topics

UsernamePublicRestriction

Register

LL1133990

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel